About Vitara Biomedical
Vitara Biomedical is a company based in Philadelphia (United States) founded in 1999. Vitara Biomedical has raised $124.99 million across 2 funding rounds from investors including Khosla Ventures, Sands Capital and Google Ventures. Vitara Biomedical offers products and services including Platform Therapy for Preterm Infants and Velocity TM pAVF System.
- Headquarter Philadelphia, United States
- SectorsHealthcare
- Phone•••• ••••
- Website vitara.com
- Social LinkedIn
- Legal Name Vitara Biomedical, Inc.
- Total Equity Funding$124.99M (USD)
in 2 rounds
- Latest Funding Round$50M (USD), Series C
Oct 2024
- InvestorsKhosla Ventures
& 4 more
Products & Services of Vitara Biomedical
Vitara Biomedical offers a comprehensive portfolio of products and services, including Platform Therapy for Preterm Infants and Velocity TM pAVF System.
Offers stable environment for premature babies to develop post-birth
Reduces reinterventions for fistula maturation in vascular procedures
Funding Insights of Vitara Biomedical
Vitara Biomedical has successfully raised a total of $124.99M across 2 strategic funding rounds. The most recent funding activity was a Series C round of $50 million completed in October 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $124.99M
- Total Rounds 2
- Last Round Series C — $50M
- First Round $74.99M
(Jul 2022)
- Investors Count 5
All 2 funding rounds of Vitara Biomedical with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2024 | $50M | Series C | – | Sands Capital | |
| Jul 2022 | $74.99M | Series C | – | – | – |
5 investors in total: 5 institutional.
Investors in Vitara Biomedical
Vitara Biomedical has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include Khosla Ventures, Sands Capital and Google Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Corporate backed venture capital fund investing in multiple sectors | – | gv.com | Mountain View, United States | |
A venture capital fund focused on deep tech innovations is managed. | – | firstsparkventures.com | - | |
Flerie is engaged in investing in biotech and pharmaceutical companies. | – | flerie.com | Stockholm, Sweden | |
Early-stage startups are funded by this venture capital firm. | 2004 | khoslaventures.com | Menlo Park, United States | |
Active, long-term growth equity investments are provided globally. | – | sandscapital.com | Arlington, United States |
Investor details for Vitara Biomedical
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Vitara Biomedical
23 people are tracked at Vitara Biomedical (7 in leadership, 16 in team).
| Name | Role | Group |
|---|---|---|
James S Mcglone | CEO | Leadership |
Erin Kriebel | Senior Director Of Quality | Leadership |
Marcus Davey | Vice President Preclinical Research | Leadership |
Rajagopalan Srinivasan | Retiring ... Director, Software Engineering | Leadership |
Chris Gregory | Vice President of Research & Development | Leadership |
James Tarmin | Director, Project Management | Leadership |
Jason Troxell | Finance Director | Leadership |
Thanu Anidharan | Manager Program Management | Team |
Tylar Farmer | SQA Engineer | Team |
Josh Propper | Quality Engineer | Team |
Stephen Markham | Research Analyst | Team |
Andre Maitre | Software Engineering Manager | Team |
Sathwik Kumar | Validation Engineer | Team |
Jeff Kiersh | Principle Mechanical Engineer | Team |
Rami Hamzey | Senior Biomedical Engineer | Team |
Vincent Iademarco | Engineering Designer | Team |
Trisha Ambe | Human Factors Engineering Manager | Team |
Daisy Herrera Cruz | Pre-clinical Research Associate II | Team |
Kenneth Botelho | Sr. Principal Software Engineer | Team |
Salma B. | Lab & Office Manager | Team |
3 more people are available in the full profile.
Complete people profiles for Vitara Biomedical
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Vitara Biomedical
3 dated milestones of Vitara Biomedical across 25 years, from founding to its latest funding, stage changes and deals.
- Founded Vitara Biomedical is founded.
- Funding First funding round of $75.0M.
- Funding Latest funding round, Series C, of $50.0M.
Web traffic of Vitara Biomedical
The website of Vitara Biomedical (vitara.com) receives about 2K visits a month.
- Monthly visits2K
▲ 45.3% vs previous month
Latest news on Vitara Biomedical
Complete news archive for Vitara Biomedical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Vitara Biomedical
10 companies that operate in the same segment as Vitara Biomedical (Pediatrics), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Owlet is recognized for developing FDA-cleared smart baby monitors. | 2013 | Lehi, Utah, United States | USD 54.96 M | USD 105.71 M | 85 | |
Therapeutics for gastrointestinal disorders, including linaclotide, are developed. | 1998 | Cambridge, Massachusetts, United States | USD 206.25 M | USD 296.15 M | 253 | |
Smart baby monitors and sleep tracking solutions are provided. | 2014 | New York, New York, United States | USD 116.6 M | – | – | |
Provider of diagnostic products for pediatrics | 2013 | Durham, North Carolina, United States | USD 95.89 M | – | – | |
Eye-tracking solutions for vision assessment and treatment are provided. | 2016 | Lod, Central District, Israel | USD 8 M | – | – | |
Patient vital signs are monitored via wearable devices and software. | 2018 | Niles, Illinois, United States | USD 71 M | – | – | |
Pediatric orthopedic devices are developed for surgical applications. | 2006 | Warsaw, United States | USD 51.55 M | USD 236.35 M | 562 | |
Gene therapy platform for rare disease treatments is developed. | 2018 | Exton, Pennsylvania, United States | USD 192.8 M | – | 41 | |
Pediatric cardiac surgical devices are developed for congenital heart defects. | 2011 | Pittsburgh, Pennsylvania, United States | USD 22.56 M | – | – | |
Drug-delivery platforms for pediatric wart treatments are developed. | 2020 | San Antonio, Texas, United States | USD 262.71 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Vitara Biomedical
Vitara Biomedical was founded in 1999 and raised its 1st funding round 23 years after it was founded.
Vitara Biomedical is headquartered in Philadelphia, United States. It is registered at Philadelphia, Pennsylvania, United States.
James S Mcglone is the current CEO of Vitara Biomedical.
Vitara Biomedical is a funded company, having raised a total of $124.99M across 2 funding rounds to date. The company's 1st funding round was a Series C of $74.99M, raised on Jul 2022.
Vitara Biomedical was founded in 1999 and is headquartered in Philadelphia, United States. Operations focus on the biomedical sector, where neonatal care services are provided to support infant health. These services encompass medical and support interventions for newborns, primarily within the local and national geography. Leadership is held by CEO James S Mcglone, overseeing activities in this specialized field.
Vitara Biomedical offers Platform Therapy for Preterm Infants and Velocity TM pAVF System.
Vitara Biomedical has 5 investors. Key investors include Khosla Ventures, Sands Capital, Google Ventures, First Spark Ventures, and Flerie.
Vitara Biomedical operates through Vitara Biomedical, Inc..